We are live on
!
Find out more
FMW
Farr Miller & Washington Portfolio holdings
AUM
$1.53B
1-Year Est. Return
32.74%
This Fund
S&P 500
This Quarter
Est. Return
-12.1%
1 Year Est. Return
+32.74%
3 Year Est. Return
+62.27%
5 Year Est. Return
+125.67%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$130M
(-11%)
Cap. Flow
+$28.4M
Cap. Flow
% of AUM
2.7%
Top 10 Holdings %
Top 10 Hldgs %
36.14%
Holding
153
New
1
Increased
53
Reduced
56
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$6.57M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$4.78M |
| 3 |
RTX Corp
RTX
|
+$4.75M |
| 4 |
Ross Stores
ROST
|
+$4.66M |
| 5 |
JPMorgan Chase
JPM
|
+$4.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.88M |
| 2 |
SLB Ltd
SLB
|
+$1.83M |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.57M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$1.54M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.47% |
| 2 | Financials | 11.42% |
| 3 | Consumer Discretionary | 10.94% |
| 4 | Consumer Staples | 10.93% |
| 5 | Technology | 10.78% |
Similar funds
MAFM
H
BOS
BU
QAM
OPU
AC
WAM
Farr Miller & Washington's Q4 2018 Portfolio in Review
As of Q4 2018, Farr Miller & Washington held 153 positions worth $1.05B, down 11% from $1.18B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Farr Miller & Washington's Q4 2018 filing shows 1 new, 53 increased, 56 reduced and 22 closed positions. Its largest new stake was Evolent Health: 153,165 shares worth $3.06M. The largest sale was CVS Health, an estimated $1.88M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- Farr Miller & Washington's largest Q4 2018 buy was Evolent Health: 153,165 shares worth $3.06M.
- Farr Miller & Washington added most to Alphabet (Google) Class A in Q4 2018, an estimated $6.57M increase.
- Farr Miller & Washington's biggest Q4 2018 reduction was CVS Health, cutting an estimated $1.88M.
- Farr Miller & Washington fully exited Precigen in Q4 2018, selling an estimated $829K.
- Farr Miller & Washington's ten largest holdings make up 36% of its $1.05B portfolio in Q4 2018.
- Farr Miller & Washington opened 1 new position and closed 22 in Q4 2018.
- Farr Miller & Washington's portfolio value fell 11% quarter-over-quarter to $1.05B.
Based on Farr Miller & Washington's 13F filing for Q4 2018, filed 14 Feb 2019.